Dysferlin and other non-red cell proteins accumulate in the red cell membrane of Diamond-Blackfan anemia patients

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pesciotta, Esther N ^a   Sriswasdi, Sira ^b,c   Tang, Hsin Yao ^b   Speicher, David W ^b,c   Mason, Philip J ^a   Bessler, Monica ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PEPTIDE TRANSPORTER 2; BETA 2 MICROGLOBULIN; DYSFERLIN; EPOXIDE HYDROLASE 1; GAMMA ADDUCIN; HEMOGLOBIN; HLA A ANTIGEN; HLA B ANTIGEN; LUNG RESISTANCE PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; PREDNISONE; PROTEOME; SERINE PALMITOYLTRANSFERASE 1; SERINE PALMITOYLTRANSFERASE 2; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLACKFAN DIAMOND ANEMIA; CHILD; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROPOIESIS; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; MEGALOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESCHOOL CHILD; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, DIAMOND-BLACKFAN; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MUSCLE PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84897989119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085504     Document Type: Article

References (42)

1. Ball S (2011) Diamond Blackfan anemia. Hematology Am Soc Hematol Educ Program 2011: 487-491.
2. Vlachos A, Dahl N, Dianzani I, Lipton JM (2013) Clinical utility gene card for: Diamond - Blackfan anemia - update 2013. Eur J Hum Genet.
3. Weiss MJ, Mason PJ, Bessler M (2012) What's in a name? Journal of Clinical Investigation 122: 2346-2349.
4. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, et al. (2008) Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology 142: 859-876.
5. Nathan DG, Clarke BJ, Hillman DG, Alter BP, Housman DE (1978) Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia. Journal of Clinical Investigation 61: 489-498. (Pubitemid 8280420)
6. Perdahl EB, Naprstek BL, Wallace WC, Lipton JM (1994) Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 83: 645-650. (Pubitemid 24043722)
7. Moniz H, Gastou M, Leblanc T, Hurtaud C, Cretien A, et al. (2012) Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis 3: e356.
8. Ohene-Abuakwa Y, Orfali KA, Marius C, Ball SE (2005) Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 105: 838-846. (Pubitemid 40070773)
9. Danilova N, Sakamoto KM, Lin S (2008) Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112: 5228-5237.
10. Jaako P, Flygare J, Olsson K, Quere R, Ehinger M, et al. (2011) Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 118: 6087-6096.
11. Gazda HT, Kho AT, Sanoudou D, Zaucha JM, Kohane IS, et al. (2006) Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 24: 2034-2044. (Pubitemid 44477128)
12. Sieff CA, Yang J, Merida-Long LB, Lodish HF (2010) Pathogenesis of the erythroid failure in Diamond Blackfan anaemia. Br J Haematol 148: 611-622.
13. Devlin EE, Dacosta L, Mohandas N, Elliott G, Bodine DM (2010) A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 116: 2826-2835.
14. Pesciotta EN, Sriswasdi S., Tang H.-Y., Mason P.J., Bessler M., Speicher D.W (2012) A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders. Journal of Proteomics.
15. Paweletz CP, Wiener MC, Bondarenko AY, Yates NA, Song QH, et al. (2010) Application of an End-to-End Biomarker Discovery Platform to Identify Target Engagement Markers in Cerebrospinal Fluid by High Resolution Differential Mass Spectrometry. Journal of Proteome Research 9: 1392-1401.
16. Neubert H, Bonnert TP, Rumpel K, Hunt BT, Henle ES, et al. (2008) Label-free detection of differential protein expression by LC/MALDI mass spectrometry. Journal of Proteome Research 7: 2270-2279.
17. Beer LA, Tang HY, Sriswasdi S, Barnhart KT, Speicher DW (2011) Systematic Discovery of Ectopic Pregnancy Serum Biomarkers Using 3-D Protein Profiling Coupled with Label-free Quantitation. Journal of Proteome Research 10: 1126-1138.
18. Franco RS, Puchulu-Campanella ME, Barber LA, Palascak MB, Joiner CH, et al. (2013) Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol 88: 44-51.
19. Yurchenco PD, Speicher DW, Morrow JS, Knowles WJ, Marchesi VT (1982) Monoclonal antibodies as probes of domain structure of the spectrin alpha subunit. Journal of Biological Chemistry 257: 9102-9107. (Pubitemid 12001878)
20. Alter BP (1979) Fetal erythropoiesis in stress hematopoiesis. Exp Hematol 7 Suppl 5: 200-209.
21. Hoffman JF (1958) Physiological characteristics of human red blood cell ghosts. J Gen Physiol 42: 9-28.
22. Sharma R, Premachandra BR (1991) Membrane-bound hemoglobin as a marker of oxidative injury in adult and neonatal red blood cells. Biochem Med Metab Biol 46: 33-44.
23. Silva JC, Denny R, Dorschel CA, Gorenstein M, Kass IJ, et al. (2005) Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 77: 2187-2200. (Pubitemid 40463836)
24. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, et al. (2006) In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108: 791-801. (Pubitemid 44154609)
25. Kakhniashvili DG, Bulla LA, Goodman SR (2004) The human erythrocyte proteome - Analysis by ion trap mass spectrometry. Molecular & Cellular Proteomics 3: 501-509. (Pubitemid 38714291)
26. De Palma A, Roveri A, Zaccarin M, Benazzi L, Daminelli S, et al. (2010) Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis. Journal of Chromatography A 1217: 5328-5336.
27. van Gestel RA, van Solinge WW, van der Toorn HW, Rijksen G, Heck AJ, et al. (2010) Quantitative erythrocyte membrane proteome analysis with Blue-native/SDS PAGE. Journal of Proteomics 73: 456-465.
28. Xu L, Pallikkuth S, Hou Z, Mignery GA, Robia SL, et al. (2011) Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells. PLoS One 6: e27884.
29. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, et al. (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20: 37-42. (Pubitemid 28410340)
30. Liu J, Aoki M, Illa I, Wu C, Fardeau M, et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31-36. (Pubitemid 28410339)
31. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, et al. (2001) Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49: 130-134. (Pubitemid 32163018)
32. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, et al. (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8: 855-861. (Pubitemid 29189053)
33. Burton NM, Bruce LJ (2011) Modelling the structure of the red cell membrane. Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire 89: 200-215.
34. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, et al. (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423: 168-172. (Pubitemid 36569539)
35. Nagaraju K, Rawat R, Veszelovszky E, Thapliyal R, Kesari A, et al. (2008) Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am J Pathol 172: 774-785. (Pubitemid 351354549)
36. de Morree A, Flix B, Bagaric I, Wang J, van den Boogaard M, et al. (2013) Dysferlin regulates cell adhesion in human monocytes. Journal of Biological Chemistry.
37. Botto M, So AK, Giles CM, Mason PD, Walport MJ (1990) HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects. Br J Haematol 75: 106-111. (Pubitemid 20157988)
38. Giles CM, Walport MJ, David J, Darke C (1987) Expression of MHC class I determinants on erythrocytes of SLE patients. Clin Exp Immunol 69: 368-374. (Pubitemid 17154246)
39. Morton JA, Pickles MM, Darley JH (1977) Increase in strength of red cell Bga antigen following infectious mononucleosis. Vox Sanguinis 32: 26-37. (Pubitemid 8034312)
40. Everett ET, Scornik JC, Davis G, Kao KJ (1990) Induction of erythrocyte HLA expression during interferon treatment and HIV infection. Hum Immunol 29: 14-22. (Pubitemid 20250603)
41. Alegretti AP, Schneider L, Piccoli AK, Monticielo OA, Lora PS, et al. (2012) Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients. Clin Dev Immunol 2012: 725684.
42. An HJ, Ryu SJ, Kim SY, Choi HR, Chung JH, et al. (2009) Age associated high level of major vault protein is p53 dependent. Cell Biochem Funct 27: 289-295.